tirzepatide news 2025 Leads Pharma Growth in with $11.4B in Sales | Brian K. Buntz posted on the topic Eli Lilly H1 2025: Tirzepatide

A new study shows that patients with type 2 diabetes who are taking GLP-1 receptor agonists may be at an increased risk for serious vision problems, including NAION

PMID: 37575352

Always be cautious about where and how you store semaglutide to avoid any risks to your health and safety

The phase 3 GLORY-1 trial was conducted in China and investigated the effects of mazdutide 4 mg and 6 mg weekly compared to placebo on weight loss in patients with obesity or overweight based on the Chinese criteria of overweight (BMI 2427) or obesity (BMI of 28) [36]

Side effects and tolerability Common side effects for both include nausea, early satiety, gastrointestinal upset, and potential gallbladder issues

Each batch is tested for purity, potency, and sterility before shipping